Investment Analysts’ Weekly Ratings Changes for HealthStream (HSTM)
HealthStream (NASDAQ: HSTM) recently received a number of ratings updates from brokerages and research firms:
- 10/25/2017 – HealthStream was downgraded by analysts at Needham & Company LLC from a “buy” rating to a “hold” rating.
- 10/25/2017 – HealthStream was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong-buy” rating. They now have a $27.00 price target on the stock. According to Zacks, “HealthStream, Inc. (HealthStream) provides Internet-based learning and research solutions for healthcare organizations. The Company’s learning products are used by healthcare organizations to meet a range of their training, certification, and development needs, while its research products provide the customers information about patients’ experiences, workforce engagement, physician relations, and community perceptions of their services. HealthStream’s products and services are organized into two segments: HealthStream Learning and HealthStream Research. It’s offers EchoCredentialing, a platform that manages medical staff credentialing and privileging processes; EchoOneApp, an enrollment platform; EchoAccess, a platform that supports hospital call centers; EchoAnalytics, which offers a range of validation tools; and EchoOnboarding, an onboarding dashboard with a workflow functionality and onboarding navigator tools. “
- 10/25/2017 – HealthStream had its price target lowered by analysts at Robert W. Baird from $30.00 to $28.00. They now have an “outperform” rating on the stock.
- 10/24/2017 – HealthStream had its “hold” rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
- 10/23/2017 – HealthStream had its “hold” rating reaffirmed by analysts at Canaccord Genuity. They now have a $25.00 price target on the stock. They wrote, “We maintain our HOLD rating and $25 PT and will reevaluate our thesis and PT following tomorrow’s conference call. We suspect shares may react favorably given the strong operating income beat and raised 2017 operating income guidance, although we note that the implied 4Q guide is disappointing versus our previous estimates and consensus. Key positive: Delivering significant upside to operating income and raising 2017 operating income guidance will be viewed favorably. In the past, investors have questioned when HSTM would begin to deliver improved profitability. Key negative: Normalized growth in Workforce Solutions. The company’s largest division experienced a slowdown in growth.””
HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.05 by $0.03. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The firm had revenue of $63.60 million for the quarter, compared to the consensus estimate of $62.48 million. During the same period in the previous year, the company earned $0.04 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
Receive News & Ratings for HealthStream Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream Inc and related companies with MarketBeat.com's FREE daily email newsletter.